Heated chemo during surgery: a new hope for ovarian cancer?
NCT ID NCT01970722
First seen Mar 24, 2026 · Last updated Jun 20, 2026 · Updated 11 times
Summary
This early-phase trial tests whether giving heated chemotherapy directly into the abdomen during surgery can help lower the risk of cancer returning in people with advanced ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants will receive the heated chemo during surgery, and some may also get additional non-heated chemo afterward. The main goal is to check for side effects and see how well patients tolerate the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT FALLOPIAN TUBE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Corona
Corona, California, 92879, United States
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope Upland
Upland, California, 91786, United States
-
Parkview Hospital Randallia
Fort Wayne, Indiana, 46805, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
heated chemotherapy (carboplatin or cisplatin) given into the abdomen during surgery
What this could lead to
If it works, this approach could help lower the chance of cancer coming back in patients with advanced or recurrent gynecologic cancers.
What could go wrong
This is a very early phase 1 trial with only 40 participants, so safety and side effects are the main focus. It is not yet known if the heated chemotherapy actually improves survival or prevents recurrence.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.